RAPT Therapeutics Inc (RAPT)
7.55
-0.35
(-4.43%)
USD |
NASDAQ |
Apr 25, 11:54
RAPT Therapeutics Net Income (Quarterly): -30.88M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -30.88M |
September 30, 2023 | -31.37M |
June 30, 2023 | -25.28M |
March 31, 2023 | -29.27M |
December 31, 2022 | -22.95M |
September 30, 2022 | -21.24M |
June 30, 2022 | -19.18M |
March 31, 2022 | -20.47M |
December 31, 2021 | -17.93M |
September 30, 2021 | -18.65M |
June 30, 2021 | -16.11M |
March 31, 2021 | -16.51M |
Date | Value |
---|---|
December 31, 2020 | -12.74M |
September 30, 2020 | -14.63M |
June 30, 2020 | -12.39M |
March 31, 2020 | -13.14M |
December 31, 2019 | -13.22M |
September 30, 2019 | -9.971M |
June 30, 2019 | -10.63M |
March 31, 2019 | -9.188M |
December 31, 2018 | -9.43M |
September 30, 2018 | -10.28M |
June 30, 2018 | -8.204M |
March 31, 2018 | -8.231M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-31.37M
Minimum
Sep 2023
-9.971M
Maximum
Sep 2019
-18.77M
Average
-17.93M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
Emergent BioSolutions Inc | -49.50M |
Avinger Inc | -5.024M |
Tonix Pharmaceuticals Holding Corp | -27.32M |
Skye Bioscience Inc | -4.420M |
Axsome Therapeutics Inc | -98.65M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 33.22M |
EPS Diluted (Quarterly) | -0.81 |
Enterprise Value | 116.04M |
Earnings Yield | -40.40% |
Normalized Earnings Yield | -33.77 |